Waqar Haque

Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy

Waqar Haque, Vivek Verma, Sandra S. Hatch et al. · Breast Cancer Research and Treatment · 2018 · 373 citations

Breast Oncology, Pathologic Complete Response, Medicine +7

Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of <i>Smad4(Dpc4)</i> Immunostaining With Pattern of Disease Progression

Christopher H. Crane, Gauri R. Varadhachary, John S. Yordy et al. · Journal of Clinical Oncology · 2011 · 285 citations · Full text

Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States

Waqar Haque, Vivek Verma, E. Brian Butler et al. · Journal of Immunotherapy · 2019 · 78 citations

Health Care Disparity, Epidemiology Of Cancer, Health Disparities +26

Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States

Vivek Verma, Waqar Haque, Taylor R. Cushman et al. · Journal of Immunotherapy · 2019 · 64 citations

Metaplastic Breast Cancer: Practice Patterns, Outcomes, and the Role of Radiotherapy

Waqar Haque, Vivek Verma, Nilan Naik et al. · Annals of Surgical Oncology · 2018 · 50 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +10